Search Results - "Thomas, Shrina"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Reduced-Dose Venetoclax Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults by Marin, Monica Pernia, Alharbi, Malak, Chhina, Arashpreet, Thomas, Shrina P, Jain, Maneesh

    Published in Blood (23-11-2021)
    “…Venetoclax is a potent selective inhibitor of the anti-apoptotic protein B-Cell Lymphoma 2 (BCL2) on tumor cells restoring the process of apoptosis among…”
    Get full text
    Journal Article
  2. 2

    Reduced-Dose Ibrutinib Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults by Chhina, Arashpreet, Marin, Monica Pernia, Thomas, Shrina P, Vallejo, Elizabeth G, Cappell, Kathryn, Jain, Maneesh

    Published in Blood (23-11-2021)
    “…Ibrutinib is an inhibitor of Bruton's tyrosine kinase (BTK) that is used for the treatment of multiple hematologic malignancies including chronic lymphocytic…”
    Get full text
    Journal Article
  3. 3

    Assessing the discordance rate of HER2 expression by immunohistochemistry between primary and secondary prostate cancer biopsies by Mabellos, Joshua, Gill, Puneet, Lap, Coen Johannes Gerardus, Zara Rozalen, Alexandra, Diao, Guoqing, Liu, Shanshan, Thomas, Shrina, Subrahmanyam, Ramesh, Nava, Victor, Jain, Maneesh Rajiv

    Published in Journal of clinical oncology (01-06-2023)
    “…e17014 Background: Preliminary evidence suggests that human epidermal growth factor receptor 2 (HER2) expression may play a role in tumor cell proliferation in…”
    Get full text
    Journal Article